Javascript must be enabled to continue!
EVALUATION OF SERUM IRON PROFILE IN BETA THALASSEMIA PATIENTS
View through CrossRef
Background: Beta-thalassemia is an inherited hemoglobinopathy caused by mutations in the beta-globin gene, resulting in reduced or absent beta-globin chain synthesis. The imbalance in globin chains leads to ineffective erythropoiesis and severe anemia, especially in transfusion-dependent individuals. In regions like Pakistan, where the carrier frequency is high, regular blood transfusions are essential for survival in beta-thalassemia major patients. However, repeated transfusions contribute to progressive iron overload, making timely monitoring and management crucial. Serum ferritin serves as a simple, noninvasive, and cost-effective biomarker for assessing iron burden.
Objective: To evaluate the serum iron profile and transfusion frequency among beta-thalassemia major patients.
Methods: This cross-sectional study included 100 electrophoresis-confirmed beta-thalassemia major patients aged 2 to 19 years, admitted at Alkhidmat Thalassemia Care Centre, Lahore. Blood samples (2–3 mL) were collected using gel separator vials. Serum ferritin levels were analyzed using both manual ELISA and automated chemiluminescence immunoassays. Hemoglobin levels and the number of lifetime transfusions were also recorded. Data were analyzed using SPSS version 17.0.
Results: Among 100 patients, 55 were male (55%) and 45 female (45%), with a mean age of 9.68 ± 4.843 years. The average number of transfusions was 92.92 ± 34.677. Mean serum ferritin concentration was 2376.72 ± 749.03 ng/mL. Ferritin levels were <1500 ng/mL in 3 patients (3%), 1500–2500 ng/mL in 64 patients (64%), and >2500 ng/mL in 33 patients (33%). Mean hemoglobin concentration was 7.208 ± 0.7062 g/dL.
Conclusion: Serum ferritin remains an accessible and reliable indicator of iron overload in beta-thalassemia major patients. The findings underscore the importance of routine monitoring and effective chelation therapy to reduce iron-induced complications, improve quality of life, and guide evidence-based patient care.
Title: EVALUATION OF SERUM IRON PROFILE IN BETA THALASSEMIA PATIENTS
Description:
Background: Beta-thalassemia is an inherited hemoglobinopathy caused by mutations in the beta-globin gene, resulting in reduced or absent beta-globin chain synthesis.
The imbalance in globin chains leads to ineffective erythropoiesis and severe anemia, especially in transfusion-dependent individuals.
In regions like Pakistan, where the carrier frequency is high, regular blood transfusions are essential for survival in beta-thalassemia major patients.
However, repeated transfusions contribute to progressive iron overload, making timely monitoring and management crucial.
Serum ferritin serves as a simple, noninvasive, and cost-effective biomarker for assessing iron burden.
Objective: To evaluate the serum iron profile and transfusion frequency among beta-thalassemia major patients.
Methods: This cross-sectional study included 100 electrophoresis-confirmed beta-thalassemia major patients aged 2 to 19 years, admitted at Alkhidmat Thalassemia Care Centre, Lahore.
Blood samples (2–3 mL) were collected using gel separator vials.
Serum ferritin levels were analyzed using both manual ELISA and automated chemiluminescence immunoassays.
Hemoglobin levels and the number of lifetime transfusions were also recorded.
Data were analyzed using SPSS version 17.
Results: Among 100 patients, 55 were male (55%) and 45 female (45%), with a mean age of 9.
68 ± 4.
843 years.
The average number of transfusions was 92.
92 ± 34.
677.
Mean serum ferritin concentration was 2376.
72 ± 749.
03 ng/mL.
Ferritin levels were <1500 ng/mL in 3 patients (3%), 1500–2500 ng/mL in 64 patients (64%), and >2500 ng/mL in 33 patients (33%).
Mean hemoglobin concentration was 7.
208 ± 0.
7062 g/dL.
Conclusion: Serum ferritin remains an accessible and reliable indicator of iron overload in beta-thalassemia major patients.
The findings underscore the importance of routine monitoring and effective chelation therapy to reduce iron-induced complications, improve quality of life, and guide evidence-based patient care.
Related Results
The Molecular Basis of Alpha-Thalassemia in the Qatari Pediatric Population
The Molecular Basis of Alpha-Thalassemia in the Qatari Pediatric Population
BackgroundAnemia is the most common hematologic abnormality that a pediatrician encounters in clinical practice. Alpha-Thalassemia (a-thal) is widely reported in the Arabian Penins...
Comprehensive analysis of a-and b-thalassemia genotypes and hematologic phenotypes
Comprehensive analysis of a-and b-thalassemia genotypes and hematologic phenotypes
Background: Guizhou Province is an area with high incidence of thalassemia. However, there are few large-sample studies on the correlation between genotypes and phenotypes in Guizh...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract
Introduction
Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
Alterations of Plasma Metabolomics Profile in Thalassemia Patients with Low Bone Mineral Density
Alterations of Plasma Metabolomics Profile in Thalassemia Patients with Low Bone Mineral Density
Background: Osteoporosis is commonly found in thalassemia patients; however, its pathogenesis is not thoroughly understood. Metabolomics is the study of metabolites in biofluids, w...
Thalassemia Phenotypes and Associated Mortality among Yemeni Patients: A Single-Center Retrospective Analysis
Thalassemia Phenotypes and Associated Mortality among Yemeni Patients: A Single-Center Retrospective Analysis
Objective: To retrospectively analyze thalassemia phenotypes and associated mortality among Yemeni patients seeking healthcare in Sana’a city, Yemen.
Methods: This retrospect...
Thalassemia Phenotypes and Associated Mortality among Yemeni Patients: A Single-Center Retrospective Analysis
Thalassemia Phenotypes and Associated Mortality among Yemeni Patients: A Single-Center Retrospective Analysis
Objective: To retrospectively analyze thalassemia phenotypes and associated mortality among Yemeni patients seeking healthcare in Sana’a city, Yemen.
Methods: This retrospect...
DIAGNOSTIC VALUE OF MENTZER INDEX FOR THALASSEMIA PREDICTION IN SUSPECTED PATIENTS OF PUNJAB
DIAGNOSTIC VALUE OF MENTZER INDEX FOR THALASSEMIA PREDICTION IN SUSPECTED PATIENTS OF PUNJAB
Thalassemia is a genetic disease and became a worldwide problem. Worldwide, about 3-8% of population are suffered from beta thalassemia. The aim of this study was to use Mentzer in...
Comparison of the Diagnostic Value of Mentzer Index and RDW Index in the Screening of Beta Thalassemia Trait and Iron Deficiency Anemia
Comparison of the Diagnostic Value of Mentzer Index and RDW Index in the Screening of Beta Thalassemia Trait and Iron Deficiency Anemia
Background: Beta thalassemia trait is one of the common forms of hemoglobinopathies in Bangladesh. Individuals having beta-thalassemia trait have microcytic hypochromic anemia and ...

